Median Technologies Reports Excellent Results from Its Independent Verification Study

17.01.2024 - Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) today announces that it has achieved very positive results from the independent verification study for its CADe/CADx1 SaMD eyonis2 LCS (Lung Cancer Screening). This ... Seite 1

Related Keywords

United States , ,Implications For Global Health ,Innovations Leading ,Youden Index ,Median Technologies ,